Drug Discovery at Advinus is presently focused on generating novel small molecule for indications in four therapeutic areas: Metabolic Diseases, Inflammatory Diseases, Pain/Neurodegenerative Diseases and Neglected Diseases of the developing world.

Project oriented multidisciplinary teams, consisting of scientists with knowledge in a specific therapeutic area, biologists, medicinal chemists and pharmaceutical scientists direct programs from concept to lead clinical candidates. Our drug discovery activity generates intellectual property that will be available for licensing at any stage from clinical candidacy onward. Preclinical development and early clinical development are also carried out by the Advinus team, with proven capabilities to generate PoC in humans.